Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T21:11:30.954Z.
Calculation as of: 2026-10-06T21:11:30.954Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a0c9e813714e0b831054d1f10aa0b6d5c0dd28cf54928773f54bac5a92e2c297
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-05-07.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$548.51M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Delcath Systems, Inc. (DCTH) | $531.98M | N/A | N/A | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $531.52M | N/A | N/A | N/A | N/A |
| Monopar Therapeutics Inc. (MNPR)vs › | $533.04M | N/A | N/A | N/A | N/A |
| Shattuck Labs, Inc. (STTK)vs › | $529.58M | N/A | N/A | N/A | N/A |
| ProKidney Corp. (PROK)vs › | $538.01M | N/A | N/A | N/A | N/A |
| Immix Biopharma, Inc. (IMMX)vs › | $524.43M | N/A | N/A | N/A | N/A |
| Altimmune, Inc. (ALT)vs › | $519.25M | N/A | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $516.76M | N/A | N/A | N/A | N/A |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $548.51M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $557.32M | N/A | 14.25x | 18.01x | 18.01x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-05-07 | 614.19x |
| 2026-05-06 | 615.40x |
| 2026-05-05 | 631.70x |
| 2026-05-04 | 600.91x |
| 2026-05-01 | 587.63x |
| 2026-04-30 | 562.27x |
| 2026-04-29 | 552.01x |
| 2026-04-28 | 572.54x |
| 2026-04-27 | 590.04x |
| 2026-04-24 | 590.04x |
| 2026-04-23 | 577.97x |
| 2026-04-22 | 611.18x |
| 2026-04-21 | 579.18x |
| 2026-04-20 | 592.46x |
| 2026-04-17 | 591.25x |
| 2026-04-16 | 589.44x |
| 2026-04-15 | 599.10x |
| 2026-04-14 | 592.46x |
| 2026-04-13 | 566.50x |
| 2026-04-10 | 541.74x |
| 2026-04-09 | 532.08x |
| 2026-04-08 | 530.27x |
| 2026-04-07 | 519.41x |
| 2026-04-06 | 521.22x |
| 2026-04-02 | 516.99x |
| 2026-04-01 | 511.56x |
| 2026-03-31 | 495.86x |
| 2026-03-30 | 472.31x |
| 2026-03-27 | 477.14x |
| 2026-03-26 | 486.80x |
| 2026-03-25 | 491.03x |
| 2026-03-24 | 477.75x |
| 2026-03-23 | 484.99x |
| 2026-03-20 | 483.18x |
| 2026-03-19 | 499.48x |
| 2026-03-18 | 501.90x |
| 2026-03-17 | 523.63x |
| 2026-03-16 | 527.86x |
| 2026-03-13 | 506.12x |
| 2026-03-12 | 507.93x |
| 2026-03-11 | 520.01x |
| 2026-03-10 | 501.29x |
| 2026-03-09 | 486.20x |
| 2026-03-06 | 483.78x |
| 2026-03-05 | 483.78x |
| 2026-03-04 | 492.84x |
| 2026-03-03 | 454.80x |
| 2026-03-02 | 474.73x |
| 2026-02-27 | 472.92x |
| 2026-02-26 | 54.34x |
| 2026-02-25 | 62.58x |
| 2026-02-24 | 60.81x |
| 2026-02-23 | 59.38x |
| 2026-02-20 | 59.65x |
| 2026-02-19 | 57.95x |
| 2026-02-18 | 57.61x |
| 2026-02-17 | 57.06x |
| 2026-02-13 | 56.45x |
| 2026-02-12 | 55.15x |
| 2026-02-11 | 57.74x |
| 2026-02-10 | 61.83x |
| 2026-02-09 | 60.81x |
| 2026-02-06 | 56.86x |
| 2026-02-05 | 53.93x |
| 2026-02-04 | 59.10x |
| 2026-02-03 | 60.94x |
| 2026-02-02 | 61.01x |
| 2026-01-30 | 60.53x |
| 2026-01-29 | 60.53x |
| 2026-01-28 | 60.60x |
| 2026-01-27 | 62.58x |
| 2026-01-26 | 64.89x |
| 2026-01-23 | 64.75x |
| 2026-01-22 | 67.82x |
| 2026-01-21 | 63.46x |
| 2026-01-20 | 62.44x |
| 2026-01-16 | 63.66x |
| 2026-01-15 | 62.58x |
| 2026-01-14 | 63.73x |
| 2026-01-13 | 64.01x |
| 2026-01-12 | 63.12x |
| 2026-01-09 | 63.46x |
| 2026-01-08 | 62.58x |
| 2026-01-07 | 64.75x |
| 2026-01-06 | 64.21x |
| 2026-01-05 | 62.92x |
| 2026-01-02 | 60.81x |
| 2025-12-31 | 61.83x |
| 2025-12-30 | 62.17x |
| 2025-12-29 | 62.30x |
| 2025-12-26 | 63.19x |
| 2025-12-24 | 63.32x |
| 2025-12-23 | 61.96x |
| 2025-12-22 | 61.62x |
| 2025-12-19 | 61.55x |
| 2025-12-18 | 60.67x |
| 2025-12-17 | 60.87x |
| 2025-12-16 | 61.35x |
| 2025-12-15 | 61.69x |
| 2025-12-12 | 63.66x |
| 2025-12-11 | 63.80x |
| 2025-12-10 | 60.60x |
| 2025-12-09 | 60.53x |
| 2025-12-08 | 58.69x |
| 2025-12-05 | 59.65x |
| 2025-12-04 | 61.28x |
| 2025-12-03 | 58.83x |
| 2025-12-02 | 56.45x |
| 2025-12-01 | 58.29x |
| 2025-11-28 | 59.10x |
| 2025-11-26 | 58.69x |
| 2025-11-25 | 55.90x |
| 2025-11-24 | 55.90x |
| 2025-11-21 | 54.06x |
| 2025-11-20 | 48.82x |
| 2025-11-19 | 51.00x |
| 2025-11-18 | 51.95x |
| 2025-11-17 | 51.68x |
| 2025-11-14 | 53.86x |
| 2025-11-13 | 51.68x |
| 2025-11-12 | 51.55x |
| 2025-11-11 | 51.75x |
| 2025-11-10 | 51.48x |
| 2025-11-07 | 51.89x |
| 2025-11-06 | 51.89x |
| 2025-11-05 | 52.16x |
| 2025-11-04 | 66.27x |
| 2025-11-03 | 69.81x |
| 2025-10-31 | 72.30x |
| 2025-10-30 | 68.84x |
| 2025-10-29 | 71.41x |
| 2025-10-28 | 74.87x |
| 2025-10-27 | 73.58x |
| 2025-10-24 | 75.51x |
| 2025-10-23 | 76.72x |
| 2025-10-22 | 76.56x |
| 2025-10-21 | 84.83x |
| 2025-10-20 | 85.07x |
| 2025-10-17 | 89.49x |
| 2025-10-16 | 92.62x |
| 2025-10-15 | 84.27x |
| 2025-10-14 | 84.67x |
| 2025-10-13 | 84.51x |
| 2025-10-10 | 77.36x |
| 2025-10-09 | 80.73x |
| 2025-10-08 | 82.50x |
| 2025-10-07 | 80.09x |
| 2025-10-06 | 80.09x |
| 2025-10-03 | 82.50x |
| 2025-10-02 | 78.88x |
| 2025-10-01 | 79.69x |
| 2025-09-30 | 79.69x |
| 2025-09-29 | 80.89x |
| 2025-09-26 | 79.69x |
| 2025-09-25 | 80.57x |
| 2025-09-24 | 81.94x |
| 2025-09-23 | 81.70x |
| 2025-09-22 | 86.11x |
| 2025-09-19 | 86.03x |
| 2025-09-18 | 87.72x |
| 2025-09-17 | 83.30x |
| 2025-09-16 | 81.86x |
| 2025-09-15 | 79.05x |
| 2025-09-12 | 80.41x |
| 2025-09-11 | 82.74x |
| 2025-09-10 | 82.66x |
| 2025-09-09 | 86.52x |
| 2025-09-08 | 86.11x |
| 2025-09-05 | 86.92x |
| 2025-09-04 | 82.50x |
| 2025-09-03 | 80.89x |
| 2025-09-02 | 80.89x |
| 2025-08-29 | 81.86x |
| 2025-08-28 | 80.73x |
| 2025-08-27 | 81.21x |
| 2025-08-26 | 82.66x |
| 2025-08-25 | 80.81x |
| 2025-08-22 | 82.66x |
| 2025-08-21 | 76.96x |
| 2025-08-20 | 76.31x |
| 2025-08-19 | 78.16x |
| 2025-08-18 | 78.88x |
| 2025-08-15 | 76.56x |
| 2025-08-14 | 77.44x |
| 2025-08-13 | 82.58x |
| 2025-08-12 | 80.73x |
| 2025-08-11 | 77.76x |
| 2025-08-08 | 73.74x |
| 2025-08-07 | 75.19x |
